2
Views
10
CrossRef citations to date
0
Altmetric
Research Article

c-kit Protein, a Transmembrane Kinase: Identification in Tissues and Characterization

, , &
Pages 4896-4903 | Received 18 Apr 1988, Accepted 01 Aug 1988, Published online: 31 Mar 2023

Literature Cited

  • Besnier, P., E. Lader, P. C. George, P. J. Bergold, F.-H. Qiu, E. E. Zuckerman, and W. D. Hardy. 1986. A new acute transforming feline retrovirus with fms homology specifies a C- terminally truncated version of the ofms protein that is different from SM-feline sarcoma virus v-fms protein. J. Virol. 60:194-203.
  • Besmer, P., J. E. Murphy, P. C. George, F. Qiu, P. J. Bergold, L. Lederman, H. W. Snyder, D. Brodeur, E. E. Zuckerman, and W. D. Hardy. 1986. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (London) 320:415-421.
  • Bishayee, S., A. H. Ross, R. Womer, and C. Scherr. 1986. Purified human platelet derived growth factor receptor has ligand-stimulated tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 83:6756-6760.
  • Brown, M. S., R. G. W. Anderson, and J. L. Goldstein. 1983. Recycling receptors: the roundtrip itinerary of migrant membrane proteins. Cell 32:663-667.
  • Carpenter, G. 1987. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56:881-914.
  • Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gill, and M. G. Rosenfeld. 1987. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (London) 328:820-823.
  • Chou, C. K., T. J. Dull, D. S. Russel, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842-1847.
  • Cooper, J. A., B. M. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. Methods En- zymol. 99:387-402.
  • Coussens, L., C. VanBeveren, D. Smith, E. Chen, R. L. Mitchell, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature (London) 320:277-280.
  • Daniel, T. O., D. F. Milfay, J. Escobedo, and L. T. Williams. 1987. Biosynthetic and glycosylation studies of cell surface platelet-derived growth factor receptors. J. Biol. Chem. 262:9778-9784.
  • Gentry, L. A., L. R. Rohrschneider, J. E. Casnellie, and E. G. Krebs. 1983. Antibodies to a defined region of pp60 v-src neutralize the tyrosine specific kinase activity. J. Biol. Chem. 258:11219-11228.
  • Hedo, J. A., L. C. Harrison, and J. Roth. 1981. Binding of insulin receptors to lectins: evidence for common carbohydrate determinants on several membrane receptors. Biochemistry 20:3385-3393.
  • Higgins, R. C., and M. E. Dahmus. 1979. Rapid visualization of protein bands in preparative SDS-polyacrylamide gels. Anal. Biochem. 93:257-260.
  • Honegger, A. M., D. Szapary, A. Schmidt, R. Lyall, E. Van Obberghen, T. J. Dull, A. Ullrich, and J. Schlessinger. 1987. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol. Cell. Biol. 7:4568-4571.
  • Hunter, T., and J. A. Cooper. 1985. Protein tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
  • Johnson, D., A. Lanahan, C. R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the human NGF receptor. Cell 32:545-554.
  • Keating, M. T., and L. T. Williams. 1988. Autocrine stimulation of intracellular PDGF receptors in v-sis transformed cells. Science 239:914-916.
  • King, C. R., H. K. Matthias, and S. A. Aaronson. 1985. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974-976.
  • Kleid, D. G., D. Yansura, B. Small, D. Dowbenko, D. M. Moore, M. J. Grubman, P. D. McKrecher, D. O. Morgan, B. H. Robertson, and H. L. Bachrach. 1981. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 241:1125-1128.
  • Kobuta, A. 1979. Use of endo- and exoglycosidases for structural studies of glycoconjugates. Anal. Biochem. 100:1-14.
  • Kraus, M. H., N. C. Popescu, S. Z. Amsbaugh, and C. R. King. 1987. Overexpression of the EGF receptor-related protooncogene erbB2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6:605-610.
  • Leal, F., L. T. Williams, K. C. Robbins, and S. A. Aaronson. 1985. Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor. Science 230:327-330.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Nilsen, T. W., P. A. Maroney, R. G. Goodwin, F. M. Rottman, L. B. Crittenden, M. A. Raines, and H. J. Kung. 1985. C-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an aminotruncated EGF receptor. Cell 41:719-726.
  • Qui, F., P. Ray, K. Brown, P. E. Barker, S. Jhanwar, F. H. Ruddle, and P. Besnier. 1988. Primary structure of c-kit: relationship with the CSF-l/PDGF receptor kinase family—oncogenic activation of v-kit involves deletion of extracellular domain and C-terminus. EMBO J. 7:1003-1011.
  • Rettenmier, C. W., J. H. Chen, M. F. Roussel, and C. J. Sherr. 1985. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 228:320-322.
  • Reynolds, F. H., W. J. M. VandeVen, J. Blomberg, and J. R. Stephenson. 1981. Differences in mechanism of transformation by independent feline sarcoma virus isolates. J. Virol. 38:1084-1089.
  • Rosen, O. M. 1987. After insulin binds. Science 237:1452-1458.
  • Rosen, O. M., R. Herrera, Y. Olowe, L. M. Petruzzelli, and M. H. Cobb. 1983. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA 80:3237-3240.
  • Roussel, M. F., T. J. Dull, C. W. Rettenmeier, P. Ralph, A. Ullrich, and C. Scherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549-552.
  • Sen, S., R. A. Houghten, C. J. Sherr, and A. Sen. 1983. Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities. Proc. Natl. Acad. Sci. USA 80:1246-1250.
  • Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/new oncogene. Science 235:177-182.
  • Sudhof, T. C., J. L. Goldstein, M. S. Brown, and D. W. Russell. 1885. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228:815-822.
  • Thoakura, N. R., and O. P. Bahl. 1987. Enzymatic deglycosylation of glycoproteins. Methods Enzymol. 138:350-359.
  • Yarden, Y., J. A. Escobedo, W.-J. Kuang, T. L. Yang-Feng, T. O. Daniel, P. M. Tremble, E. Y. Chen, M. E. Ando, R. W. Harkins, U. Francke, V. A. Fried, A. Ullrich, and L. T. Williams. 1986. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature (London) 323:226-232.
  • Yarden, Y., W. J. Kuang, T. Yang-Feng, L. Coussens, S. Munemitsu, T. J. Dull, E. Chen, J. Schlessinger, U. Francke, and A. Ullrich. 1987. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6:3341-3351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.